Cancer-targeted drug discovery can be achieved by transcriptomics screening on patients. Here this group reports a drug target screening model built upon triple-negative breast cancer (TNBC) cohort and drug database with the selected drug pair exhibiting effective pyroptosis induction and TNBC tumor growth inhibition.
- Boshu Ouyang
- Caihua Shan
- Zhiqing Pang